LUPKYNIS Registry Study
Research payments
$2,614,596
Through program year 2025, $2,614,596 in research payments was reported against LUPKYNIS Registry Study, across 709 payments, paid by Aurinia Pharma U.S., Inc..
- Paid by
- Aurinia Pharma U.S., Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $938,004 | 229 |
| 2024 | Research | $1,008,829 | 303 |
| 2023 | Research | $667,763 | 177 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Meggan MacKay Manhasset, NY Named on 23 payments
- June Yao Houston, TX Named on 19 payments
- Jennifer Rogers Chapel Hill, NC Named on 19 payments
- Alla Rudinskaya Danbury, CT Named on 17 payments
- Osama Amro Seattle, WA Named on 16 payments
- Alan Kivitz Duncansville, PA Named on 15 payments
- Amit Johnsingh Temple Terrace, FL Named on 14 payments
- Keith Bartolomei Providence, RI Named on 13 payments
- Ashar Luqman Sioux City, IA Named on 12 payments
- Daniel Wallace Beverly Hills, CA Named on 12 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.